Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry.

Abstract:

:New biologic agents have changed the paradigm of rheumatoid arthritis treatment, leading to improvement in managing patients' refractory to classical DMARDs. Anti-TNF-alpha is used as first-line treatment in patients failing to respond to classical DMARDs. However, up to 50% of patients fail to respond to these drugs or develop adverse events leading to treatment discontinuation: in these cases the optimal treatment strategy is still a matter of debate even if trying with a second anti-TNF-alpha is considered a good option. We report data of patients switching from a first to a second anti-TNF-alpha from an Italian registry of patients with rheumatoid arthritis, showing that switching is valuable in patients stopping a first anti-TNFalpha drug. The patients with higher disease activity levels and those stopping the first anti-TNFalpha treatment because of a lack of efficacy are very likely to respond to the second treatment.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Caporali R,Sarzi-Puttini P,Atzeni F,Gorla R,Filippini M,Marchesoni A,Favalli EG,Bobbio-Pallavicini F,Montecucco C

doi

10.1016/j.autrev.2009.12.010

subject

Has Abstract

pub_date

2010-04-01 00:00:00

pages

465-9

issue

6

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(09)00219-5

journal_volume

9

pub_type

杂志文章
  • Multiple sclerosis: geoepidemiology, genetics and the environment.

    abstract::Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system characterized by relapses and remissions. The risk of acquiring this complex disease is associated with exposure to environmental factors in genetically susceptible individuals. The epidemiology of MS has been exte...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.010

    authors: Milo R,Kahana E

    更新日期:2010-03-01 00:00:00

  • Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases.

    abstract::Heat-shock protein (Hsp) family is made up of heterogeneous proteins of which Hsp60 members are the most studied. It is now generally admitted that Hsp60 is not only a mitochondrial component but can be localized on the membrane cell surface. Considered as a signal danger following infections, Hsp60 can induce the pro...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.01.012

    authors: Alard JE,Dueymes M,Youinou P,Jamin C

    更新日期:2007-08-01 00:00:00

  • Catastrophic antiphospholipid (Asherson's) syndrome and genetic thrombophilic disorders in obstetrics.

    abstract::Catastrophic antiphospholipid syndrome (CAPS) (Asherson's Syndrome), is a life-threatening condition characterized by a rapidly progressive thromboses resulting in a multiorgan dysfunction syndrome (MODS), evidence of systemic inflammatory response syndrome (SIRS) in the presence of antiphospholipid antibodies. CAPS d...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.06.011

    authors: Makatsariya A,Asherson RA,Bitsadze V,Baimuradova S,Akinshina S

    更新日期:2006-12-01 00:00:00

  • Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

    abstract:BACKGROUND:According to criteria for the classification of Systemic Lupus Erythematosus (SLE), thrombocytopenia is one of the disease-defining hematologic disorders. Since the recognition of Antiphospholipid Syndrome (APS), thrombocytopenia was frequently reported but several studies yielded contradictory results on th...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2019.102395

    authors: Chock YP,Moulinet T,Dufrost V,Erkan D,Wahl D,Zuily S

    更新日期:2019-11-01 00:00:00

  • Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases.

    abstract::Systemic rheumatic diseases (SRDs) are associated with accelerated atherosclerosis. It has recently been recognised that chronic inflammation is an important factor in the development of atherosclerotic plaque and endothelial dysfunction. The levels of biomarkers such as serum pentraxin 3 (PTX3), an innate immunity pr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.001

    authors: Atzeni F,Turiel M,Hollan I,Meroni P,Sitia S,Tomasoni L,Sarzi-Puttini P

    更新日期:2010-10-01 00:00:00

  • Polyarteritis nodosa: A contemporary overview.

    abstract::Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis predominantly targeting medium-sized arteries. PAN is a rare form of vasculitis, and the precise frequency of this disease is difficult to determine. The major environmental factor associated with PAN is HBV infection. The pathogenesis of "idiopathic PAN"...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.02.015

    authors: De Virgilio A,Greco A,Magliulo G,Gallo A,Ruoppolo G,Conte M,Martellucci S,de Vincentiis M

    更新日期:2016-06-01 00:00:00

  • Environmental factors and the geoepidemiology of juvenile idiopathic arthritis.

    abstract::Juvenile idiopathic arthritis (JIA), the most common chronic rheumatic disease of childhood, is a clinically heterogeneous group of disorders characterized by chronic inflammatory arthritis. JIA is considered to be an autoimmune disease, which is a result of immune reaction caused or triggered by environmental factors...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.018

    authors: Berkun Y,Padeh S

    更新日期:2010-03-01 00:00:00

  • Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases.

    abstract:OBJECTIVE:To describe the clinical and immunologic features of 6 patients with rheumatic disease and Hepatitis C Virus (HCV) chronic infection, treated with anti-TNF alpha drugs. PATIENTS AND METHODS:Six patients, with repeated positive serology for HCV infection, were affected by Rheumatoid arthritis (RA) (4 cases), ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2008.05.002

    authors: Cavazzana I,Ceribelli A,Cattaneo R,Franceschini F

    更新日期:2008-12-01 00:00:00

  • Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus.

    abstract::Dendritic cells (DCs) constitute a heterogeneous population of professional antigen presenting cells which are the initiators and key regulators for both immunity and tolerance induction. The significance and impact of DC biology in contemporary immunology and medical research is heightened by the award of the 2011 No...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.03.004

    authors: Chan VS,Nie YJ,Shen N,Yan S,Mok MY,Lau CS

    更新日期:2012-10-01 00:00:00

  • Factors influencing polyautoimmunity in systemic lupus erythematosus.

    abstract:OBJECTIVE:Since characterization of the extent to which particular combinations of autoimmune diseases (ADs) occur in excess of that expected by chance may offer new insights into possible common pathophysiological mechanisms, polyautoimmunity (i.e., ADs co-occurring within patients) in systemic lupus erythematosus (SL...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2009.10.001

    authors: Rojas-Villarraga A,Toro CE,Espinosa G,Rodríguez-Velosa Y,Duarte-Rey C,Mantilla RD,Iglesias-Gamarra A,Cervera R,Anaya JM

    更新日期:2010-02-01 00:00:00

  • Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.

    abstract::A few scores predicting the short-term risk of mortality in Systemic sclerosis (SSc) have been reported to date. Our study aimed to create a predictive 15-year all-cause mortality score at the time of the diagnosis of SSc. The study was based on the Spanish Scleroderma Registry (RESCLE). The cohort was split up in der...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102507

    authors: Rubio-Rivas M,Corbella X,Guillén-Del-Castillo A,Tolosa Vilella C,Colunga Argüelles D,Argibay A,Vargas Hitos JA,Todolí Parra JA,González-Echávarri C,Ortego-Centeno N,Trapiella Martínez L,Rodríguez Carballeira M,Marín Ballvé A,Pl

    更新日期:2020-05-01 00:00:00

  • Hemopoietic stem cell transplantation in rheumatic diseases--an update.

    abstract::Hematopoietic stem cell transplant (HSCT) for autoimmune diseases has been recognized as a potential treatment for patients who have failed conventional therapy. Autologous (self) donor cells have been preferred over allogeneic (HLA-matched) cells for rescue after high dose immunotherapy, given the previous higher rat...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.03.003

    authors: de Buys P,Khanna D,Furst DE

    更新日期:2005-09-01 00:00:00

  • Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.

    abstract::The presence of anti-nuclear antibodies (ANA) is a hallmark of systemic autoimmune rheumatic diseases (SARD). The indirect immunofluorescence (IIF) assay on HEp-2 cells is a commonly used test for the detection of ANA and was recently recommended as the screening test of choice by a task force of the American College ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.005

    authors: Mahler M,Hanly JG,Fritzler MJ

    更新日期:2012-07-01 00:00:00

  • Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review.

    abstract:BACKGROUND AND OBJECTIVE:Numerous autoimmune diseases (AIDs) have been linked to chronic spontaneous urticaria (CSU). Here, we provide the first extensive and comprehensive evaluation of the prevalence of AIDs in patients with CSU and vice versa. METHODS:A Pubmed and Google Scholar search was performed to identify stu...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.10.003

    authors: Kolkhir P,Borzova E,Grattan C,Asero R,Pogorelov D,Maurer M

    更新日期:2017-12-01 00:00:00

  • Autoimmune and proinflammatory activity of oxidized immunoglobulins.

    abstract:AIMS:Oxidation reactions can modify protein activity or specificity. Recently, a novel redox-reactive family of autoantibodies was described, which indicated involvement of altered antibodies (beside altered antigens) into autoimmune reactions. The aim of our study was to determine the binding capacity alterations of e...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2008.04.005

    authors: Omersel J,Jurgec I,Cucnik S,Kveder T,Rozman B,Sodin-Semrl S,Bozic B

    更新日期:2008-07-01 00:00:00

  • Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease.

    abstract::Numerous inflammatory rheumatic diseases occurring in premenopausal women require the use of high doses of glucocorticoids (GC). It was believed for many years that premenopausal women were, at least to some extent, protected from bone loss associated with GC therapy. However, epidemiological studies performed in prem...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s1568-9972(03)00056-9

    authors: Franchimont N,Canalis E

    更新日期:2003-06-01 00:00:00

  • CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.

    abstract::There is strong evidence that a quantitative and/or functional deficiency in CD4+CD25+ regulatory T cells (T(reg) cells) plays a key role in the pathogenesis of many human autoimmune diseases. Therefore, targeting regulatory T cells with novel forms of immunotherapy should provide a means for successfully battling aut...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2005.06.001

    authors: Beyersdorf N,Hanke T,Kerkau T,Hünig T

    更新日期:2006-01-01 00:00:00

  • The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis.

    abstract::Rheumatoid arthritis (RA) is a chronic inflammatory joint disease characterized by a distinctive pattern of bone and joint destruction. RA patients have an increased risk of death. The incidence and prevalence of RA vary across populations, statistical methods, and disease definitions. In North America and Northern Eu...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.019

    authors: Tobón GJ,Youinou P,Saraux A

    更新日期:2010-03-01 00:00:00

  • Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.

    abstract::It has been noted since 1981 that late primary infection with the Epstein-Barr virus (EBV) in adolescence or young adulthood can account for the epidemiology of multiple sclerosis (MS), including the association with higher socio-economic status, the latitudinal variation in prevalence, the effects of migration on the...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.01.017

    authors: Pender MP

    更新日期:2009-06-01 00:00:00

  • Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.

    abstract::Autoantibodies are a hallmark in the diagnosis of many systemic autoimmune rheumatic diseases (SARD) including idiopathic inflammatory myopathies (IIM). Based on their specificity, autoantibodies in IIM are grouped into myositis specific (MSA) and myositis associated autoantibodies (MAA). Among the MSA, autoantibodies...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.01.022

    authors: Mahler M,Miller FW,Fritzler MJ

    更新日期:2014-04-01 00:00:00

  • Infectome: a platform to trace infectious triggers of autoimmunity.

    abstract::The "exposome" is a term recently used to describe all environmental factors, both exogenous and endogenous, which we are exposed to in a lifetime. It represents an important tool in the study of autoimmunity, complementing classical immunological research tools and cutting-edge genome wide association studies (GWAS)....

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.12.005

    authors: Bogdanos DP,Smyk DS,Invernizzi P,Rigopoulou EI,Blank M,Pouria S,Shoenfeld Y

    更新日期:2013-05-01 00:00:00

  • 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

    abstract::The 'Task Force on Catastrophic Antiphospholipid Syndrome (CAPS)' was developed on the occasion of the 14th International Congress on Antiphospholipid Antibodies. The objectives of this Task Force were to assess the current knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, prec...

    journal_title:Autoimmunity reviews

    pub_type:

    doi:10.1016/j.autrev.2014.03.002

    authors: Cervera R,Rodríguez-Pintó I,Colafrancesco S,Conti F,Valesini G,Rosário C,Agmon-Levin N,Shoenfeld Y,Ferrão C,Faria R,Vasconcelos C,Signorelli F,Espinosa G

    更新日期:2014-07-01 00:00:00

  • Risk of scleroderma according to the type of immune checkpoint inhibitors.

    abstract:INTRODUCTION:Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Among them, ICIs-induced systemic sclerosis (SSc) is poorly known. METHODS:To better characterize this irAE, our comprehensive approach combined the description of ICIs-induced scleroderma cases, the systematic ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102596

    authors: Terrier B,Humbert S,Preta LH,Delage L,Razanamahery J,Laurent-Roussel S,Mestiri R,Beaudeau L,Legendre P,Goupil F,Hadjadj J,Stolzenberg MC,Treluyer JM,Westeel V,Valnet-Rabier MB,Wislez M,Mouthon L,Chouchana L

    更新日期:2020-08-01 00:00:00

  • Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.

    abstract::Mesenchymal stem cells (MSCs) are non-hematopoietic, multipotent progenitor cells which can be isolated from various human adult tissues. In recent years, MSCs have been shown to possess broad immunoregulatory capabilities, modulating both adaptive and innate immunity. This review discusses the documented immunomodula...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.01.005

    authors: Ben-Ami E,Berrih-Aknin S,Miller A

    更新日期:2011-05-01 00:00:00

  • Myocarditis in auto-immune or auto-inflammatory diseases.

    abstract::Myocarditis is a major cause of heart disease in young patients and a common precursor of heart failure due to dilated cardiomyopathy. Some auto-immune and/or auto-inflammatory diseases may be accompanied by myocarditis, such as sarcoidosis, Behçet's disease, eosinophilic granulomatosis with polyangiitis, myositis, an...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.05.021

    authors: Comarmond C,Cacoub P

    更新日期:2017-08-01 00:00:00

  • Haplotype specific alteration of diabetes MHC risk by olfactory receptor gene polymorphism.

    abstract::Evidence for genes associated with risk for Type 1 diabetes (T1D) in the extended region of the major histocompatibility complex (MHC) genes is accumulating. The aim of this study was to investigate the association pattern of the extended MHC region with T1D susceptibility to identify effects independent of well estab...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.05.001

    authors: Jahromi MM

    更新日期:2012-12-01 00:00:00

  • Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity.

    abstract::Alpha-actinin (α-actinin) is a ubiquitous cytoskeletal protein, which belongs to the superfamily of filamentous actin (F-actin) crosslinking proteins. It is present in multiple subcellular regions of both muscle and non-muscle cells, including cell-cell and cell-matrix contact sites, cellular protrusions and stress fi...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.12.009

    authors: Oikonomou KG,Zachou K,Dalekos GN

    更新日期:2011-05-01 00:00:00

  • Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study.

    abstract::The aim of this study is to assess the long-term effectiveness and safety of IL1Ra in Schnitzler syndrome (SchS). Between 2010 and 2012, we performed a nationwide survey among French internal medicine departments to identify SchS patients. We retrospectively analyzed the long-term efficacy and safety of IL1Ra and the ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.autrev.2014.08.031

    authors: Néel A,Henry B,Barbarot S,Masseau A,Perrin F,Bernier C,Kyndt X,Puechal X,Weiller PJ,Decaux O,Ninet J,Hot A,Aouba A,Astudillo L,Berthelot JM,Bonnet F,Brisseau JM,Cador B,Closs-Prophette F,Dejoie T,de Korwin JD,Dh

    更新日期:2014-10-01 00:00:00

  • Incidence and nature of infectious disease in patients treated with anti-TNF agents.

    abstract::Tumor necrosis factor alpha (TNF-alpha) inhibitors offer a targeted therapeutic strategy that contrasts with the nonspecific immunosuppressive agents traditionally used to treat most inflammatory diseases. These biologic agents have had a significant impact in ameliorating the signs and symptoms of inflammatory rheuma...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.08.006

    authors: Raychaudhuri SP,Nguyen CT,Raychaudhuri SK,Gershwin ME

    更新日期:2009-12-01 00:00:00

  • Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review.

    abstract:OBJECTIVE:To describe safety and efficacy of rituximab in patients with systemic sclerosis. METHODS:We included 13 patients with systemic sclerosis treated with rituximab and pooled with 40 additional patients from the literature. SSc rituximab untreated patients were matched to rituximab treated ones. RESULTS:Thirte...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.autrev.2017.12.010

    authors: Thiebaut M,Launay D,Rivière S,Mahévas T,Bellakhal S,Hachulla E,Fain O,Mekinian A

    更新日期:2018-06-01 00:00:00